Azenta (AZTA) vs ICU Medical (ICUI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
ICU Medical (ICUI) has outperformed Azenta (AZTA) over the past year, gaining 32.1% versus a gain of 16.8%. Over five years, ICUI leads with a -32.4% price change compared with -65.3% for AZTA. ICU Medical is the larger company by market cap ($3.90 billion vs $1.57 billion), about 2.5 times the size.
On valuation, ICU Medical trades at a lower forward P/E (16.2x vs 65.0x for Azenta).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZTA | ICUI |
|---|---|---|
| Share price | $35.89 | $156.03 |
| Market cap | $1.57B | $3.90B |
| 1-day change | -8.79% | -2.32% |
| YTD return | +7.91% | +9.36% |
| 1-year return | +16.79% | +32.12% |
| 5-year return | -65.31% | -32.41% |
| P/E ratio (TTM) | — | 131.12 |
| Forward P/E | 64.96 | 16.18 |
| EPS (TTM) | $-2.47 | $1.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $2.23B |
| Revenue growth (YoY) | — | -6.33% |
| Net income (latest FY) | — | $732.00K |
| Gross margin | — | 36.84% |
| Operating margin | — | 1.92% |
| Net margin | — | 0.03% |
| 52-week high | $46.41 | $192.85 |
| 52-week low | $15.93 | $112.50 |
| Distance from 52-week high | -22.67% | -19.09% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +3.09% | +23.94% |
| Average volume | 852.82K | 278.57K |
| Shares outstanding | 43.81M | 25.01M |
| Employees | 2,900 | 13,000 |
| Sector | Technology | Health Care |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ICU Medical is about 2.5 times larger than Azenta by market value ($3.90B vs $1.57B).
- ICUI has outperformed AZTA by 15.3 percentage points over the past year.
- The two companies sit in different sectors: Azenta in Technology and ICU Medical in Health Care.
About Azenta
AZTA stock →Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
Technology · Industrial Machinery/Components · 2,900 employees
About ICU Medical
ICUI stock →ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.
Health Care · Medical/Dental Instruments · 13,000 employees
AZTA vs ICUI FAQ
Which is bigger, Azenta or ICU Medical?
ICU Medical (ICUI) is larger, with a market capitalization of $3.90B compared with $1.57B for Azenta (AZTA).
Which stock has performed better over the past year, AZTA or ICUI?
ICUI returned +32.12% over the past 12 months, compared with +16.79% for AZTA (price return, excluding dividends). Past performance does not predict future results.
Are Azenta and ICU Medical in the same industry?
No. Azenta is in the Technology sector, while ICU Medical is in Health Care.